The purpose of this article is to investigate the efficacy and safety of frovatriptan plus dexketoprofen 25 or 37.5 mg ( FroDex25 or FroDex37 .5 , respectively ) compared to that of frovatriptan 2.5 mg ( Frova ) in menstrually related migraine ( MRM ) .